HPB : the official journal of the International Hepato Pancreato Biliary AssociationHumansCarcinomaPancreatic DuctalNeoadjuvant TherapyFemale
Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenocarcinoma during surgical exploration.
Filip Gryspeerdt, Luís Filipe Abreu de Carvalho, Niki Rashidian, Suzane Ribeiro, Anne Hoorens, Karen Geboes, Frederik Berrevoet
Published: 202610.1016/j.hpb.2025.10.003
Abstract
BACKGROUND: For unexpected locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) found during surgical exploration, surgeons can risk an incomplete resection or abort surgery to administer salvage neoadjuvant chemotherapy (sNACT). We aim to e…
Preview only. Read the full abstract at the source